ALAN G. WALTON, PH.D.

Corporate Board Profile

Tech Score: 0/100

ACADIA PHARMACEUTICALS INC

Filing Date	Source Excerpt
2010-04-23	Alan G. Walton: Fees Earned or Paid in Cash includes $13,250 in Board of Directors, Compensation Committee and Nominating and Corporate Governance Committee meeting fees. Option Awards includes the fair value of 10,000 stock options and 34,722 stock options (from the conversion of a $25,000 annual retainer) granted on June 12, 2009 with an exercise price of $2.16. As of December 31, 2009, an aggregate of 123,270 stock options that had been granted to Dr. Walton were outstanding.

Filing Date

Source Excerpt

2010-04-23

Alan G. Walton: Fees Earned or Paid in Cash includes $13,250 in Board of Directors, Compensation Committee and Nominating and Corporate Governance Committee meeting fees. Option Awards includes the fair value of 10,000 stock options and 34,722 stock options (from the conversion of a $25,000 annual retainer) granted on June 12, 2009 with an exercise price of $2.16. As of December 31, 2009, an aggregate of 123,270 stock options that had been granted to Dr. Walton were outstanding.

Data sourced from SEC filings. Last updated: 2026-03-14